Precision Fermentation and AI: How SMEY Is Exploring New Cosmetic Oils
An interview published on September 4, 2026, by *The Beauty Analyst* outlines the R&D approach of SMEY, a Franco-German company with headquarters in Paris and a laboratory in Munich. The technology relies on a library of yeasts, genomic analyses, lipid data, and modeling tools designed to guide fermentation experiments. This coverage highlights an ongoing technological program rather than a platform launch that took place in September.

Changing the Starting Point for Ingredient Research
In traditional approaches, formulators often begin with a known vegetable oil and attempt to adjust its properties by combining it with other ingredients. An approach based on yeast fermentation partially reverses this logic: biological diversity becomes a space for exploring lipid profiles. Yeasts can accumulate oils with compositions that vary according to their genetics and cultivation conditions. SMEY’s objective is to catalog these variations, identify those with potential for specific cosmetic functions, and then produce them under controlled conditions. While this method does not eliminate formulation constraints, it creates new possibilities for combinations in terms of composition, sensory properties, and stability.
NOY and Lipid Atlas: Data as an Exploration Layer
SMEY describes a living library called NOY (Neobank of Yeasts), alongside a catalog of oil profiles known as the Lipid Atlas. The September interview mentions over 366 characterized oils. Sequencing data, metabolic measurements, and fatty acid profiles are used to link a given strain to its production potential. Artificial intelligence models help prioritize experiments, avoiding the need to test every single microorganism indiscriminately. The company notes that it prioritizes the selection of strains with a high capacity for lipid accumulation. The predictive performance estimates cited in the interview are figures provided by the company itself; generalizing these would require knowledge of the validation dataset, experimental conditions, and margins of uncertainty.
From genome to tactile experience: the true multi-scale challenge
While measuring a fatty acid profile after extraction and analysis is relatively straightforward, predicting the sensory experience an oil will provide within a complete cosmetic formula is far more complex. Factors such as viscosity, spreadability, polarity, component distribution, compatibility with surfactants, and behavior on the skin all come into play. Furthermore, a formula often includes other ingredients, involves specific manufacturing conditions, and entails complex interactions with the epidermis. Consequently, R&D must integrate microbial genetics, lipid biochemistry, the physical chemistry of mixtures, and sensory evaluation. In the interview, SMEY acknowledges that predicting sensory characteristics—beyond the chemical profiling of the oils—remains an unresolved technical challenge.
Fermentation, reproducibility, and maturity
Once a strain has been selected, fermentation allows for the production of the substance under controlled conditions. However, performance observed at a small scale must be verified in larger reactors; factors such as yield, contamination, resource consumption, extraction, and purification can alter the overall outcome. From a cosmetic perspective, it is also necessary to characterize oxidative stability, compatibility with formulations, and relevant toxicological or regulatory profiles. An ingredient that performs well in an isolated test may behave differently when incorporated into a finished product. This distinction is particularly significant when claims emphasize sustainability: environmental benefits must be evaluated at the level of the entire process and value chain, rather than being automatically inferred from the mere use of fermentation.
Technology monitoring: bridging biology, formulation, and intellectual property
Approaches like that of SMEY blur the lines between microbiology laboratories, bioinformatics, ingredient development, and cosmetic formulation. Structured monitoring can compare biological libraries, selection strategies, process patents, compositional data, and evidence of functionality. It can also facilitate partnerships with entities specializing in characterization or modeling. For beauty R&D teams, the value lies in the ability to track specific areas ofresearch before these are translated into new, commercially available ingredients. GraphMyTech can help map these technological trajectories and the stakeholders driving them.




Comments